In this Papers Podcast, Dr. Sam Chawner discusses his JCPP Advances paper ‘Neurodevelopmental dimensional assessment of young children at high genomic risk of neuropsychiatric conditions’ (doi.org/10.1002/jcv2.12162). Sam is the first author of the paper.

There is an overview of the paper, methodology, key findings, and implications for practice.

Discussion points include:
- What are copy-number variants (CNVs) and how they impact child development.
- Insight into what 22q11.2 deletion syndrome is, how it is typically diagnosed, and how it is associated with psychiatric risk.
- Implications for clinicians and CAMH professionals.
- Whether there are adequate interventions targeted at early age groups.
- Recommendations for prevention, detection, and the targeting of interventions.